Swiss National Bank Buys 500 Shares of Integer Holdings Co. (NYSE:ITGR)

Swiss National Bank boosted its holdings in Integer Holdings Co. (NYSE:ITGR) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,900 shares of the medical equipment provider’s stock after purchasing an additional 500 shares during the period. Swiss National Bank owned about 0.20% of Integer worth $8,733,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Loomis Sayles & Co. L P boosted its stake in Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock worth $69,943,000 after purchasing an additional 15,446 shares during the period. Jane Street Group LLC raised its holdings in shares of Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after acquiring an additional 28,572 shares in the last quarter. Verition Fund Management LLC raised its holdings in shares of Integer by 17.4% during the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock valued at $451,000 after buying an additional 515 shares in the last quarter. Versant Capital Management Inc raised its holdings in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after buying an additional 183 shares in the last quarter. Finally, KBC Group NV raised its holdings in shares of Integer by 83.3% during the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after buying an additional 726 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Down 1.0 %

ITGR stock opened at $115.07 on Friday. Integer Holdings Co. has a 1-year low of $107.11 and a 1-year high of $146.36. The business has a fifty day moving average price of $132.59 and a 200-day moving average price of $132.31. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $3.87 billion, a P/E ratio of 34.25, a P/E/G ratio of 1.72 and a beta of 1.24.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The firm had revenue of $449.50 million for the quarter, compared to analysts’ expectations of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Equities analysts forecast that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on ITGR. Benchmark raised their price target on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Truist Financial lifted their price objective on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Wells Fargo & Company restated an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Finally, Citigroup lifted their price objective on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $149.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.